01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology

More documents

Recommendations

Info

Bergemann J, Kuhlcke K, Fehse B, Ratz I, Ostertag W, Lother H (1995) Excision of specific DNA-sequences from integrated retroviral vectors via site-specific recombination. Nucleic Acids Res 23, 4451-4456. Berns KI, Linden RM (1995) The cryptic life style of adenoassociated virus. Bioessays 17, 237-245. Beutler E (1997) Gaucher disease. Curr Opin Hematol 4, 19- 23. Bi W, Kim YG, Feliciano ES, Pavelic L, Wilson KM, Pavelic ZP, Stambrook PJ (1997) An HSVtk-mediated local and distant antitumor bystander effect in tumors of head and neck origin in athymic mice. Cancer Gene Ther 4, 246-252. Bianchi, M.E., Beltrame, M. and Paonessa, G. (1989) Specific recognition of cruciform DNA by nuclear protein HMG1. Science 243, 1056-1059. Bicknell R and Harris AL (1996) Mechanisms and therapeutic implications of angiogenesis. Curr Opin Oncol 8, 60-65. Blaese RM, Culver KW, Miller AD, Carter CS, Fleisher T, Clerici M, Shearer G, Chang L, Chiang Y, Tolstoshev P, Greenblatt JJ, Rosenberg SA, Klein H, Berger M, Mullen CA, Ramsey WJ, Muul L, Morgan RA, and Anderson WF (1995) T lymphocyte-directed gene therapy for ADA - SCID: Initial trial results after 4 years. Science 270, 475-480. Block A, Chen SH, Kosai K, Finegold M, Woo SL (1997) Adenoviral-mediated herpes simplex virus thymidine kinase gene transfer: regression of hepatic metastasis of pancreatic tumors. Pancreas 15, 25-34. Bloom BR (1996) A perspective on AIDS vaccines. Science 272, 1888-1890. Blumenthal R, Seth P, Willingham MC, Pastan I (1986) pHdependent lysis of liposomes by adenovirus. Biochemistry 25, 2231-2237. Bode J, Bartsch J, Boulikas T, Iber M, Mielke C, Schübeler D, Seibler J, and Benham C (1998) Transcription-promoting genomic sites in mammalia: their elucidation and architectural principles. Gene Ther Mol Biol 1, 551-580. Bodnar, J.W., Hanson, P.I., Polvino-Bodnar, M., Zempsky, W., and Ward, D.C. (1989) The terminal regions of adenovirus and minute virus of mice DNAs are preferentially associated with the nuclear matrix in infected cells. J Virol. 63, 4344- 4353. Bohenzky RA, LeFebvre RB, Berns KI (1988) Sequence and symmetry requirements within the internal palindromic sequences of the adeno-associated virus terminal repeat. Virology 166, 316-327. Bohn MC and Choi-Lundberg DL (1998) Neurotrophic factor gene therapy for neurodegenerative diseases. Gene Ther Mol Biol 1, 265-277. Boletta A, Benigni A, Lutz J, Remuzzi G, Soria MR, Monaco L (1997) Nonviral gene delivery to the rat kidney with polyethylenimine. Hum Gene Ther 8, 1243-1251. Bongartz J-P, Aubertin A-M, Milhaud PG, and Lebleu B (1994) Improved biological activity of antisense oligonucleotides conjugated to a fusogenic peptide. Nucleic Acids Res 22, 4681-4688. Boulikas: An overview on gene therapy 132 Bookstein R, Shew J-Y, Chen P-L, Scully P, and Lee W-H (1990) Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science 247, 712-715. Border WA, Noble NA (1995) Targeting TGF-β for treatment of disease. Nature Med 1, 1000-1001. Bordignon C, Notarangelo LD, Nobili N, Ferrari G, Casorati G, Panina P, Mazzolari E, Maggioni D, Rossi C, Servida P, Ugazio AG, and Mavilio F (1995) Gene therapy in peripheral blood lymphocytes and bone marrow for ADA - immunodeficient patients. Science 270, 470-475. Boris-Lawrie KA and Temin HM (1993) Recent advances in retrovirus vector technology. Curr Opin Genet Dev 3, 102- 109. Bornstein SR, Uhlmann K, Haidan A, Ehrhart-Bornstein M, Scherbaum WA (1997) Evidence for a novel peripheral action of leptin as a metabolic signal to the adrenal gland: leptin inhibits cortisol release directly. Diabetes 46, 1235- 1238. Borrelli E, Heyman R, Hsi M, and Evans RM (1988) Targeting of an inducible toxic phenotype in animal cells. Proc Natl Acad Sci USA 85, 7572-7576. Boulikas T (1994) A compilation and classification of DNA binding sites for protein transcription factors from vertebrates. Crit. Rev. Euk. Gene Expression 4, 117-321. Boulikas T (1995a) Phosphorylation of transcription factors and the control of the cell cycle. Crit Rev Eukar. Gene Expression 5, 1-77. Boulikas T (1995b) Chromatin domains and prediction of MAR sequences. Int Rev Cytol. 162A, 279-388. Boulikas T (1996a) Cancer gene therapy and immunotherapy. Int J Oncol 9, 941-954. Boulikas T (1996b) Gene therapy to human diseases: ex vivo and in vivo studies. Int J Oncol 9, 1239-1251. Boulikas T (1996c) DNA lesion-recognizing proteins and the p53 connection. Anticancer Res 16, 225-242. Boulikas T (1996d) Liposome DNA delivery and uptake by cells. Oncol Rep. 3, 989-995. Boulikas T (1996e) Common structural features of replication origins in all life forms J. Cell. Biochem. 60, 297-316. Boulikas T (1997) Gene therapy of prostate cancer: p53, suicidal genes, and other targets. Anticancer Res 17, 1471-1506. Boulikas T (1998) Nucleocytoplasmic trafficking: implications for the nuclear import of plasmid DNA during gene therapy. Gene Ther Mol Biol 1, 713-740. Boussif (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 92, 7297-7301. Boussif O, Zanta MA, Behr JP (1996) Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold. Gene Ther 3, 1074-1080. Bowles NE, Eisensmith RC, Mohuiddin R, Pyron M, Woo SL (1996) A simple and efficient method for the concentration and purification of recombinant retrovirus for increased hepatocyte transduction in vivo. Hum Gene Ther 7, 1735- 1742.
Brady HJM, Miles CG, Pennington DJ, Dzierzak EA (1994) Specific ablation of human immunodeficiency virus Tatexpressing cells by conditionally toxic retroviruses. Proc Natl Acad Sci USA 91, 365-369. Braithwaite AW, Sturzbecher H-W, Addison C, Palmer C, Rudge K, Jenkins JR (1987) Mouse p53 inhibits SV40 origin-dependent DNA replication. Nature 329, 458-460. Bramson JL, Hitt M, Addison CL, Muller WJ, Gauldie J, Graham FL (1996) Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of interleukin-12. Hum Gene Ther 7, 1995-2002. Brancolini C, Benedetti M, Schneider C (1995) Microfilament reorganization during apoptosis: the role of Gas2, a possible substrate for ICE-like proteases. EMBO J 14, 5179-5190. Brewster SF, Simons JW (1994) Gene therapy in urological oncology: Principles, strategies and potential. Eur Urol 25, 177-182. Breyne P, Van Montagu M, Depicker A, and Gheysen G. (1992) Characterization of a plant scaffold attachment region in a DNA fragment that normalizes transgene expression in tobacco. Plant Cell 4, 463-471. Bridgen A and Elliott RM (1996) Rescue of a segmented negative-strand RNA virus entirely from cloned complementary DNAs. Proc Natl Acad Sci USA 93, 15400- 15404. Brooks EE, Gray NS, Joly A, Kerwar SS, Lum R, Mackman RL, Norman TC, Rosete J, Rowe M, Schow SR, Schultz PG, Wang X, Wick MM, Shiffman D (1997) CVT-313, a specific and potent inhibitor of CDK2 that prevents neointimal proliferation. J Biol Chem 272, 29207-29211. Brooks, A.R., Nagy, B.P., Taylor, S., Simonet, W.S., Taylor, J.M., and Levy-Wilson, B. (1994) Sequences containing the second-intron enhancer are essential for transcription of the human apolipoprotein B gene in the livers of transgenic mice. Mol Cell Biol 14, 2243-2256. Buchkovich, K., Duffy, L.A. and Harlow, E. (1989) The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58, 1097-1105. Budker V, Zhang G, Knechtle S, Wolff JA (1996) Naked DNA delivered intraportally expresses efficiently in hepatocytes. Gene Ther 3, 593-598. Bugge TH, Flick MJ, Daugherty CC, Degen JL (1995) Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev 9, 794-807. Bullough PA, Hughson FM, Skehel JJ, Wiley DC (1994) Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371, 37-43. Burfeind P, Chernicky CL, Rininsland F, Ilan J, Ilan J (1996) Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells In vivo. Proc Natl Acad Sci USA 93, 7263-7268. Burns JC, Friedmann T, Driever W, Burrascano M, Yee JK (1993) Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high Gene Therapy and Molecular Biology Vol 1, page 133 133 titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci USA 90, 8033- 8037. Bushman FD and Miller MD (1997) Tethering human immunodeficiency virus type 1 preintegration complexes to target DNA promotes integration at nearby sites. J Virol 71, 458-464. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P (1995) Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269, 546-549. Canman CE, Gilmer TM, Coutts SB, and Kastan MB (1995) Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev 9, 600-611. Cannon PM, Kim N, Kingsman SM, Kingsman AJ (1996) Murine leukemia virus-based Tat-inducible long terminal repeat replacement vectors: a new system for anti-human immunodeficiency virus gene therapy. J Virol 70, 8234- 8240. Canonico AE, Conary JT, Meyrick BO, Brigham KL (1994) Aerosol and intravenous transfection of human α1antitrypsin gene to lungs of rabbits. Am J Respir Cell Mol Biol 10, 24-29. Cao L, Zheng Z-C, Zhao Y-C, Jiang Z-H, Liu Z-G, Chen S-D, Zhou C-F, and Liu X-Y (1995) Gene therapy of Parkinson disease model rat by direct injection of plasmid DNAlipofectin complex. Hum Gene Ther 6, 1497-1501. Capaccioli S, Di Pasquale G, Mini E, Mazzei T, Quattrone A (1993) Cationic lipids improve antisense oligonucleotide uptake and prevent degradation in cultured cells and in human serum. Biochem Biophys Res Commun 197, 818- 825. Caputo A, Rossi C, Bozzini R, Betti M, Grossi MP, Barbanti- Brodano G, Balboni PG (1997) Studies on the effect of the combined expression of anti-tat and anti-rev genes on HIV-1 replication. Gene Ther 4, 288-295. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439. Carmeliet P, Moons L, Dewerchin M, Mackman N, Luther T, Breier G, Ploplis V, Muller M, Nagy A, Plow E, Gerard R, Edgington T, Risau W, Collen D (1997) Insights in vessel development and vascular disorders using targeted inactivation and transfer of vascular endothelial growth factor, the tissue factor receptor, and the plasminogen system. Ann N Y Acad Sci 811, 191-206. Carreau M, Quilliet X, Eveno E, Salvetti A, Danos O, Heard J- M, Mezzina M, and Sarasin A (1995) Functional retroviral vector for gene therapy of xeroderma pigmentosum group D patients. Hum Gene Ther 6, 1307-1315. Caruso M, Pham-Nguyen K, Kwong YL, Xu B, Kosai KI, Finegold M, Woo SL, Chen SH (1996) Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma. Proc Natl Acad Sci USA 93, 11302-11306.
Page 1 and 2:
Gene Ther Mol Biol Vol 1, 1-172. Ma
Page 3 and 4:
I. Introduction Monumental progress
Page 5 and 6:
The use of retroviral vectors in hu
Page 7 and 8:
displaying the cleavable EGF domain
Page 9 and 10:
molecules in the nucleus (Lowe and
Page 11 and 12:
sensitive mutations which allow pro
Page 13 and 14:
processed as described in panel A s
Page 15 and 16:
On the contrary, the payload capaci
Page 17 and 18:
in K562 human erythroleukemia cells
Page 19 and 20:
defective HSV virus (DeLuca and Sch
Page 21 and 22:
complex into the cytosol from the e
Page 23 and 24:
Gene Therapy and Molecular Biology
Page 25 and 26:
delivered by Sendai virus-liposome
Page 27 and 28:
plasmids with the cell surface, tra
Page 29 and 30:
infected by adenovirus alone; infec
Page 31 and 32:
Page 33 and 34:
B. Transcription factor binding sit
Page 35 and 36:
A closely related family of ubiquit
Page 37 and 38:
cells. I-CreI is a member of this c
Page 39 and 40:
Page 41 and 42:
C. Considerations of chromatin stru
Page 43 and 44:
Page 45 and 46:
A. The molecular basis of cancer im
Page 47 and 48:
fragments, or heat shock proteins c
Page 49 and 50:
ecombinant vaccinia virus expressin
Page 51 and 52:
HIV-1 envelope DNA construct develo
Page 53 and 54:
inding sites A GYYY oriented in opp
Page 55 and 56:
Page 57 and 58:
Prives, 1994). Whereas the wild-typ
Page 59 and 60:
mutant p53 (mutations on p53 are wi
Page 61 and 62:
master regulator of the cell cycle
Page 63 and 64:
Work from several groups has shown
Page 65 and 66:
chromatin condensation, drop in pH,
Page 67 and 68:
Figure 23. A pathway leading to the
Page 69 and 70:
Excessive necrotic death in cells o
Page 71 and 72:
implantation, and similar processes
Page 73 and 74:
normal cells in the surroundings. T
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
A bicistronic retroviral vector (Ha
Page 81 and 82: C. Antisense ras gene transfer for
Page 83 and 84: equal to 6.0 showed S1 hyperreactiv
Page 85 and 86: protein (e.g. Smith et al, 1995; Fo
Page 87 and 88: transduced primary mouse fibroblast
Page 89 and 90: IL-1 - receptor antagonist protein
Page 91 and 92: p53 lung cancer retroviru s MHC cla
Page 93 and 94: Gene Therapy and Molecular Biology
Page 95 and 96: designed by immunization with porti
Page 97 and 98: Isolation of an RNA aptamer that ca
Page 99 and 100: induction of human apoE in neonate
Page 101 and 102: atrium in heart, endothelial cells
Page 103 and 104: which eliminated tumors in small an
Page 105 and 106: C. Transfer of other genes against
Page 109 and 110: significant reduction in neointima
Page 111 and 112: (Prehn et al, 1996); this implies a
Page 113 and 114: B. Approaches to gene therapy of RA
Page 115 and 116: of human immunoglobulin and antigen
Page 117 and 118: A. Etiology and mechanisms of destr
Page 121 and 122: However, CsA also inhibits the acti
Page 123 and 124: The peptide kinin, after binding to
Page 125 and 126: intake when administered to adrenal
Page 127 and 128: Introgen Therapeutics (Austin and H
Page 129 and 130: When a subfragment of only 513 bp o
Page 131: Armentano D, Zabner J, Sacks C, Soo
Page 135 and 136: Chen J, Stickles RJ, Daichendt KA (
Page 137 and 138: Day ML, Wu S, Basler JW (1993) Pros
Page 139 and 140: Farmer G, Bargonetti J, Zhu H, Frie
Page 141 and 142: Giovannangeli C, Perrouault L, Escu
Page 143 and 144: the neoplastic phenotype by replace
Page 145 and 146: integrate in a site-specific fashio
Page 147 and 148: Li R, Waga S, Hannon GJ, Beach D, S
Page 149 and 150: adiation-induced apoptosis in the g
Page 151 and 152: Nakaya T, Iwai S, Fujinaga K, Sato
Page 153 and 154: Polyak K, Xia Y, Zweier JL, Kinzler
Page 155 and 156: macrophages from simian immunodefic
Page 157 and 158: intimal hyperplasia in a rat caroti
Page 159 and 160: Trono D, Feinberg MB, Baltimore D (
Page 161 and 162: Wattiaux R, Jadot M, Warnier-Pirott
Page 163 and 164: similar to mammalian interleukin-1
Page 167 and 168: 24. Gene Marking /Infectious Diseas
Page 169 and 170: Drug 50. Gene Therapy /Phase I /Can
Page 171 and 172: 76. Gene Therapy /Phase I /Cancer /
Page 173 and 174: 99. Gene Therapy /Phase II /Cancer
Page 175 and 176: 120. Gene Therapy /Phase I /Monogen
Page 179 and 180: cancer not specified) /Immunotherap
show all

01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?